The report on the evaluation of the management of H1N1 influenza in the European Union calls for the independence of the EU when it comes to developing its own assessment of the seriousness of threats and the risks arising from them, rather than relying on the research of experts funded by pharmaceutical companies.
Raport gripiviiruse H1N1 ohjamise hindamise kohta Euroopa Liidus kutsub ELi üles sõltumatusele hinnangute välja töötamisel ohtude ja nendest tulenevate riskide raskuse kohta, selle asemel et tugineda ravimifirmade rahastatavate ekspertide uurimustele.